ZymoGenetics, Inc. (NASDAQ:ZGEN.DL)

CAPS Rating: No stars

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Recs

0
Player Avatar PlanToWin (22.20) Submitted: 11/19/2008 9:36:22 AM : Underperform Start Price: $3.63 ZGEN.DL Score: -132.87

Someone is running out of cash...

Featured Broker Partners


Advertisement